Moderna
MRNA
#1106
Rank
โ‚น2.074 T
Marketcap
โ‚น5,229
Share price
-5.35%
Change (1 day)
117.09%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น280.77 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.20 Billion. In 2025 the company made an earning of -โ‚น263.09 Billion, an increase over its 2024 earnings that were of -โ‚น341.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น280.77 Billion6.72%
2025 -โ‚น263.09 Billion-23.03%
2024 -โ‚น341.79 Billion-8.22%
2023 -โ‚น372.41 Billion-140.65%
2022 โ‚น916.12 B-27.81%
2021 โ‚น1.268 T-1911.15%
2020 -โ‚น70.07 Billion44.7%
2019 -โ‚น48.42 Billion28.63%
2018 -โ‚น37.65 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.478 T-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.505 T-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น1.254 T-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.53 Billion-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.23 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.99 Billion-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.95 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น15.25 Billion-94.86%๐Ÿ‡บ๐Ÿ‡ธ USA